Developmental toxicity of doxorubicin hydrochloride in embryo-larval stages of zebrafish

Bio-Medical Materials and Engineering

Volumn 24, Issue 1, 2014, Pages 909-916

  Chang, Can ^a   Wu, Shao Ling ^a   Zhao, Xin Dong ^a   Zhao, Chun Ting ^a   Li, Yan Hui ^a  

^a QINGDAO UNIVERSITY   (China)

Author keywords

developmental toxicity; Doxorubicin hydrochloride; embryotoxicity; zebrafish

Indexed keywords

CLINICAL PRACTICES; DEVELOPMENTAL TOXICITY; DOXORUBICIN HYDROCHLORIDE; EMBRYOTOXICITY; POST-FERTILIZATION; SUB-LETHAL EFFECTS; ZEBRAFISH; ZEBRAFISH EMBRYOS;

BIOMEDICAL ENGINEERING; BIOTECHNOLOGY;

TOXICITY;

DOXORUBICIN;

BODY HEIGHT; CONFERENCE PAPER; DEVELOPMENTAL TOXICITY; EMBRYO; EMBRYO MORTALITY; HEART RATE; NONHUMAN; PRIORITY JOURNAL; STEREOMICROSCOPY; ZEBRA FISH;

DEVELOPMENTAL TOXICITY; DOXORUBICIN HYDROCHLORIDE; EMBRYOTOXICITY; ZEBRAFISH;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BODY SIZE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; EMBRYO, NONMAMMALIAN; HEART; HEART RATE; HYDROGEN-ION CONCENTRATION; TEMPERATURE; TIME FACTORS; ZEBRAFISH;

EID: 84891081092     PISSN: 09592989     EISSN: None     Source Type: Journal    
DOI: 10.3233/BME-130885     Document Type: Conference Paper

References (22)

1. R. H. Blum, S. K. Carter, Adriamycin: A new anticancer drug with significant clinical activity, Ann. Intern. Med. 80(1974), 249-259.
2. M. Yagmurca, H. Erdoganb, M. Iraz, A. Songur, M. Ucar, E. Fadilliogluf, Caffeic acid phenethyl ester as a protective agent against doxorubicin nephrotoxicity in rats, Clin. Chim. Acta. 348(2004), 27-34.
3. M. A. Ibrahim, O. M. Ashour, Y. F. Ibrahim, H. I. El-Bitar, W. Gomaa, S. R. Abdel-Rahim, Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity, Pharmacol. Res. 60(2009), 373-381.
4. M. Tokarska-Schlattner, M. Zaugg, C. Zuppinger, T. Wallimann, U. Schlattner, New insights into doxorubicin-induced cardiotoxicity: The critical role of cellular energetics, J. Mol. Cell. Cardiol. 41(2006), 389-405.
5. M. A. Lopes, A. Meisel, U. Dirnagl, F. D. Carvalho, M. L. Bastos, Doxorubicin induces biphasic neurotoxicity to rat cortical neurons, Neurotoxicology 29(2008), 286-293.
6. T. Pfeiffer, U. Krause, U. Thome, A. Rajewski, M. Skorzek, M. E. Scheulen, Tissue toxicity of doxorubicin in first and second hyperthermic isolated limb perfusion an experimental study in dogs, Eur. J . Surg. Onc. 23(1997), 439-444.
7. L. I. Zon, R. T. Peterson, In vivo drug discovery in the zebrafish, Nat. Rev. Drug Discov. 4(2005), 35-44.
8. D. Li, C. L. Lu, J. Wang, W. Hu, Z. F. Cao, D. G. Sun, H. F. Xia, X. Ma, Developmental mechanisms of arsenite toxicity in zebrafish (Danio rerio) embryos, Aquat. Toxicol. 91(2009), 229-237.
9. Y. Li, W. M. Wang, Toxicity and teratogenic effects of busulfan in early developing embryo and larva of zebrafish (Danio Rerio), Ecological Science 27(2008), 368-375.
10. S. Weigt, N. Huebler, T. Braunbeck, F. W. Landenberg, T. H. Broschard, Zebrafish teratogenicity test with metabolic activation (mDarT): Effects of phase I activation of acetaminophen on zebrafish Danio rerio embryos, Toxicology 275(2010), 36-49.
11. M. Brand, M. Granato, Keeping and raising zebrafish //Nüsslein- Volhard C, Dahm R. Zebrafish: A practical approach. Oxford: Oxford University Press 2002.
12. A. Hallare, K. Nagel, H. R. Kohler, R. Triebskorn, Comparative embryotoxicity and proteotoxicity of three carrier solvents to zebrafish (Danio rerio) embryos, Ecotox. Environ. Safe. 63(2006), 378-388.
13. J. H. He, S. Y. Guo, F. Zhu, J. J. Zhu, Y. X. Chen, C. J. Huang, J. M. Gao, Q. X. Dong, Y. X. Xuan, C. Q. Li, A zebrafish phenotypic assay for assessing drug-induced hepatotoxicity, J. Pharmacol. Toxicol. Methods 67(2012), 1-8.
14. E. J. Calabrese, L. A. Baldwin, Inorganics and hormesis, Crit. Rev. Toxicol. 33(2003), 215-304.
15. Y. Du, H. X. Lou, Catechin and proanthocyanidin B4 from grape seeds prevent doxorubicin-induced toxicity in cardiomyocytes, Eur. J. Pharmacol. 591(2008), 96-101.
16. J. K. Kang, Y. J. Lee, K. O. No, E. Y. Jung, J. H. Sung, Y. B. Kim, S. Y. Nam, Ginseng intestinal metabolite-I (GIM-I) reduces doxorubicin toxicity in the mouse testis, Reprod. Toxicol. 16(2002), 291-298.
17. E. Insa, M. Zamorano, R. López, Critical review of medical waste legislation in Spain, Resour. Conserv. Recy. 54(2010), 1048-1059.
18. A. V. Hallare, H. R. Kohler, R. Triebskorn, Development toxicity and stress protein responses in zebrafish embryos after exposure to diclofenac and its solvents, DMSO, Chemosphere 56(2004) 659-666.
19. T. Luckenbach, M. Kilian, R. Triebskorn, A. Oberemm, Fish early life stage tests as a tool to assess embryo toxic potentials in small streams, Journal of Aquatic Ecosystem Stress Recovery 8(2001), 355-370.
20. M. M. Du, D. D. Zhang, C. Z. Yan, X. Zhang, Developmental toxicity evaluation of three hexabromocyclododecane diastereoisomers on zebrafish embryos, Aquat. Toxicol. 112-113(2012), 1-10.
21. M. A. Denvir, C. S. Tucker, J. J. Mullins, Systolic and diastolic ventricular function in zebrafish embryos: Influence of norepenephrine, MS-222 and temperature, BMC Biotechnol. 8(2008), 21-29.
22. P. D. Torre, G. Mazue, A. Podesta, D. Moneta, U. Sammartini, A. R. Imondi. Protection against doxorubicin-induced cardiotoxicity in weanling rats by dexrazoxane, Cancer Chemother. Pharmacol. 43(1999), 151-156.